Search Results - "Diaz, Dina V."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study

    Over-the-counter short-acting β2-agonist purchase and asthma-related health outcomes: a post hoc analysis of the SABINA III study by Price, David, Beekman, Maarten J. H. I., Mattarucco, Walter Javier, Barriga-Acevedo, Rocio Martina, Wang, Hao-Chien, Diaz, Dina V., Khattab, Adel, Pacheco Gallego, Manuel, Al Zaabi, Ashraf, Farouk, Hisham, Attar-Zadeh, Darush

    Published in NPJ primary care respiratory medicine (01-11-2024)
    “…This post-hoc analysis of the SABINA III study evaluated the association of short-acting β 2 -agonist (SABA) prescriptions and self-reported over-the-counter…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia

    Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia by Wang, Hao-Chien, Djajalaksana, Susanthy, Sharma, Latha, Theerakittikul, Theerakorn, Lim, Hui Fang, Yoo, Kwang Ha, Yu-Lin, Andrea Ban, Diaz, Dina V., Yang, Lala, Beekman, Maarten J.H.I.

    Published in The World Allergy Organization journal (01-10-2023)
    “…BackgroundThe extent of short-acting Beta-2-agonist (β2-agonist) (SABA) use across Asian countries is not well documented. As part of the SABA use IN Asthma…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non‐frequently exacerbating COPD patients: The FLASH randomized controlled trial

    Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non‐frequently exacerbating COPD patients: The FLASH randomized controlled trial by Frith, Peter A., Ashmawi, Samiha, Krishnamurthy, Srikanth, Gurgun, Alev, Hristoskova, Sashka, Pilipovic, Virginia, Hamann, Anna Marie, Backer, Arthur, Olsson, Petter, Kostikas, Konstantinos, Diaz, Dina V.

    Published in Respirology (Carlton, Vic.) (01-12-2018)
    “…ABSTRACT Background and objective Combination long‐acting β2‐agonist/long‐acting muscarinic antagonist (LABA/LAMA) has demonstrated superior clinical outcomes…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Short-acting β2-agonist Prescription Patterns in Patients with Asthma in the Philippines: Results from SABINA III

    Short-acting β2-agonist Prescription Patterns in Patients with Asthma in the Philippines: Results from SABINA III by Diaz, Dina V., Nicodemus, Leilanie A., Parena-Santiago, Evangeline L., Capalla, Marie Elaine V., Samoro, Ronnie Z., Bayate-Jabines, Bryna Kimberly, Orcasitas, Jessie F., Hernandez-Matibag, MiranilaMiranila, Matibag, Ronnel S., Bernardo, Janet C., Garcia, Erica Frances H., Beekman, Maarten JHI

    Published in Acta medica Philippina (2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    CHALLENGES IN THE DEVELOPMENT OF A MEDICAL SURVEILLANCE SYSTEM FOR PNEUMOCONIOSES AND OTHER ASBESTOS-RELATED DISEASES IN THE PHILIPPINES

    CHALLENGES IN THE DEVELOPMENT OF A MEDICAL SURVEILLANCE SYSTEM FOR PNEUMOCONIOSES AND OTHER ASBESTOS-RELATED DISEASES IN THE PHILIPPINES by Fadrilan-Camacho, Vivien Fe F, Quizon, Romeo R, Diaz, Dina V, Manaloto, Angelica Noelle P

    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: